NHMRC Ethics Award
14 March, 2013 by Susan WilliamsonNominations for the NHMRC 2013 Ethics Award close on 22 March 2013.
Biolife Science $5m ASX listing to progress cancer vaccine
14 March, 2013 by Susan WilliamsonAustralian shareholders are being given the opportunity to buy into Biolife Science with a vaccine that shows potential to combat stomach (gastric) and breast cancer.
Robots play role in dementia treatment
11 March, 2013 by Susan WilliamsonProving the benefits and cost-effectiveness of animal robots in the treatment of dementia is the focus of a Griffith research study.
Anti-ageing protein linked to pancreatic cancer
06 February, 2013 by Tim DeanSirtuin, which is known for its link to ageing, has been associated with pancreatic cancer, raising the prospect of new treatments.
Discovery paves way for new gastric cancer treatment
17 January, 2013 by Tim DeanDrugs that inhibit a protein involved in the growth of colon and gastric cancers could be developed into a new treatment.
Insulin’s molecular handshake caught in the act
10 January, 2013 by Tim DeanResearchers at WEHI have used the Australian Synchrotron to generate the world’s first 3D images of insulin docking with cells, a finding that could lead to improved treatments for diabetes.
BioDiem partner close to filing for vaccine exports
12 December, 2012 by Dylan Bushell-EmblingBioDiem (ASX:BDM) partner Serum Institute of India will file for WHO approval in early 2013 to export flu vaccines based on BioDiem's LAIV platform.
Patrys (ASX:PAB) hits myeloma trial milestone
10 December, 2012 by Dylan Bushell-EmblingPatrys (ASX:PAB) has completed the main round of dosing for the first three patients enrolled in a German trial of its PAT-SM6 antibody in multiple myeloma.
Cavatak shows potential against bladder cancer
29 November, 2012 by Dylan Bushell-EmblingEarly research into Viralytics' (ASX:VLA) Cavatak oncolytic virus shows it effectively targets receptors on bladder cancer tissue.
Getting to the heart of Prader-Willi Syndrome
19 November, 2012 by Tim DeanResearchers at the Garvan Institute have found a sign that the rare genetic disorder, Prader-Willi Syndrome, is linked to problems in the autonomic nervous system.
Comment: Medical research key to improving the health and wealth of Australia
16 November, 2012 by Staff WritersProfessor Brendan Crabb, incoming President of AAMRI, outlines the priorities he sees for health and medical research in Australia at a time of budget cuts and systemic challenges.
Sir Gus Nossal and Ita Buttrose receive gongs at Research Australia Awards
15 November, 2012 by Staff WritersAustralia’s leading health and medical researchers and advocates have been recognised in the Research Australia Awards.
Garvan team solve autoimmune mystery
09 November, 2012 by Tim DeanA team at the Garvan Institute has solved a longstanding mystery as to how some autoimmune diseases can be triggered by wayward B cells.
Predicting cancer: it’s all in the numbers
07 November, 2012 by Tim DeanAustralian researchers have developed a statistical model that will help identify people with a high risk of bowel and endometrial cancer.
Next generation sequencing reveals pancreatic cancer’s secrets
29 October, 2012 by Tim DeanA new genomic study shows pancreatic cancer is not just a single cancer but has many variations, requiring potentially many different treatments.
